Macrophages are the gatekeepers of intestinal immune homeostasis as they discriminate
between innocuous antigens and potential pathogens to maintain oral tolerance. However …

Introduction The ESPEN guideline presents a multidisciplinary focus on clinical nutrition in
inflammatory bowel disease (IBD). Methodology The guideline is based on extensive …

The management plan for a patient with Crohn's disease should take into account the
activity, site and behaviour of disease, and should always be discussed with the patient …

Non-communicable diseases (NCDs)(mainly cardiovascular diseases, cancers, chronic
respiratory diseases and type 2 diabetes) are the main causes of death worldwide. Their …

Background Randomized trials investigating the efficacy of aminosalicylates for the
treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A …

Eating habits have changed dramatically over the years, leading to an imbalance in the ratio
of n-6/n-3 polyunsaturated fatty acids (PUFAs) in favour of n-6 PUFAs, particularly in the …

Studies over several decades have documented the beneficial actions of n-3
polyunsaturated fatty acids (PUFAs), which are plentiful in fish oil, in different disease states …

The objective was to systematically review the efficacy and safety of n-3 (omega-3 fatty
acids, fish oil) for maintaining remission in Crohn's disease (CD) and ulcerative colitis (UC) …

Background & Aim: Despite their well known anti-inflammatory actions, the clinical
usefulness of omega-3 PUFA in inflammatory bowel disease is controversial. We aimed to …

Background The anti‐inflammatory effects of n‐3 (omega‐3 fatty acids, fish oil) have been
suggested to be beneficial in chronic inflammatory disorders such as inflammatory bowel …